A Delphi survey of 16 expert genetics and cancer health professionals and 16 service users with cancer and a BRCA1/BRCA2 pathogenic variant agreed that information about inheritance, genetic testing, cancer risks and the management of hereditary cancer were key messages for cancer patients. The gene discussed is BRCA2; the disease is cancer.